Decision on Stem Cell Therapeutic | GenomeWeb

The US District Court of Appeals for the DC Circuit ruled this week that the Food and Drug Administration can regulate stem cells as drugs, reports Regulatory Focus. The ruling upholds a lower court decision from 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Biotech Court

Then Again, No

Open Emails

GINA Goes to School

This Week in Science

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.